At the Center for Investigational Therapeutics, body imaging is an important part of the process that determines if new cancer drugs are effective.

When patients participate in Phase I trials, imaging technology such as PET scans and MRIs show doctors if a particular drug is working to shrink or eliminate tumors.

For more information about imaging, view the Molecular Imaging website.

Center for Investigational Therapeutics ~ Phone: 801-587-5559 ~ This e-mail address is being protected from spambots. You need JavaScript enabled to view it